000 | 02244ngm a2200349 a 4500 | ||
---|---|---|---|
001 | HST2118_1_2 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 080121s2009 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a2118 _bHenry Stewart Talks |
035 | _a(UkLoHST)1456 | ||
035 | _a(UkLU-K)001155563 | ||
040 |
_aUkLU-K _beng _cUkLU-K |
||
100 | 1 |
_aLanier, Lewis L., _u(University of California, San Francisco, USA) _4spk |
|
245 | 1 | 0 |
_aNK cells in viral immunity _h[electronic resource] / _cLewis L. Lanier. |
260 |
_aLondon : _bHenry Stewart Talks, _c2009. |
||
300 |
_a1 online resource (1 streaming video file (38 min.) : _bcolor, sound). |
||
490 | 1 |
_aNatural killer cell biology : natural killer cell-mediated immunity to pathogens and cancer, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchonized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: Why do we have NK cells? -- Importance in viral immunity -- NK cell responses to interferon alpha/beta and cytokines induced by virus -- Control of replication in viruses -- Mouse cytomegalovirus (MCMV) -- Ly49 receptors -- Inhibitory and activating Ly49 receptors -- Direct recognition of virus-infected cells by NK cells -- Ly49H is the receptor for m157 MCMV glycoprotein -- Why did m157 evolve and why is it maintained? -- Ly49 genes are polymorphic -- Virus-driven NK receptor evolution -- Is Ly49H an exception or do other activating Ly49 receptors protect against MCMV? -- Direct recognition of virus-infected cells by NK cells -- NK cells and cytomegalovirus -- NK cells and poxviruses -- Natural cytotoxicity receptors -- NK cells in human viral immunity -- Association of KIR genes with viral infection. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 2 | _aCytotoxicity, Immunologic. | |
650 | 2 | _aKiller Cells, Natural. | |
650 | 2 | _aNeoplasms. | |
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pNatural killer cell biology : natural killer cell-mediated immunity to pathogens and cancer. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/1456/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/440/ _3Series |
999 |
_c77676 _d77676 |